You have 9 free searches left this month | for more free features.

DNA Repair

Showing 1 - 25 of 8,755

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)

Recruiting
  • Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
  • Clinuvel Investigational Site, United Kingdom
    CLINUVEL Investigational Site
Nov 9, 2022

Natural History Study for DNA Repair Disorders

Not yet recruiting
  • DNA Repair Disorder
  • +3 more
  • Interval History
  • +4 more
  • Minneapolis, Minnesota
    University of Minnesota- Twin Cities
Aug 8, 2022

Examination of Clinical and Laboratory Abnormalities in

Recruiting
  • Cockayne Syndrome
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

    Not yet recruiting
    • Metastatic Malignant Solid Neoplasm
    • Unresectable Malignant Solid Neoplasm
    • Biopsy
    • +2 more
    • (no location specified)
    Jan 14, 2023

    DNA Repair and Genetic Susceptibility to Lung Cancer

    Active, not recruiting
    • Lung Cancer
    • +2 more
    • Blood draw and Questionnaires
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 3, 2022

    Ultraviolet Rays; Injury, DNA Adduct Formation, DNA Damage, Radiation Induced Trial in Copenhagen NV (Ultraviolet radiation)

    Active, not recruiting
    • Ultraviolet Rays; Injury
    • +3 more
    • Ultraviolet radiation
    • Copenhagen NV, Denmark
      Bispebjerg Hospital, Department of Dermatology
    Jul 19, 2022

    Pancreas Cancer Trial in Scottsdale (Lurbinectedin 4 MG Injection [Zepzelca])

    Recruiting
    • Pancreas Cancer
    • Lurbinectedin 4 MG Injection [Zepzelca]
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Aug 8, 2022

    Prediction of Radiation-induced Late Intestinal Injury

    Not yet recruiting
    • Radiation-induced Intestinal Injury
    • NCRT+TME
    • (no location specified)
    Feb 19, 2023

    Embryo DNA Repair Capacity Project

    Completed
    • Infertility
    • double strand break
    • Basking Ridge, New Jersey
      Reproductive Medicine Assoicates of New Jersey
    Jan 13, 2022

    Skin Cancer Trial in Fairborn (Ultraviolet B Radiation, No Ultraviolet B Radiation)

    Not yet recruiting
    • Skin Cancer
    • Ultraviolet B Radiation
    • No Ultraviolet B Radiation
    • Fairborn, Ohio
      Wright State Physicians
    Mar 11, 2022

    Prostate Adenocarcinoma Trial in Philadelphia (Niraparib Pill)

    Recruiting
    • Prostate Adenocarcinoma
    • Niraparib Pill
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 29, 2022

    Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

    Recruiting
    • Hormone Sensitive Metastatic Prostate Cancer
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Jul 13, 2022

    MSI-H Colorectal Cancer Trial (colorectal resection)

    Completed
    • MSI-H Colorectal Cancer
    • colorectal resection
    • (no location specified)
    May 22, 2023

    Prostate Cancer, Adenocarcinoma of the Prostate Trial in Providence (Olaparib Pill, Prostatectomy)

    Terminated
    • Prostate Cancer
    • Adenocarcinoma of the Prostate
    • Olaparib Pill
    • Prostatectomy
    • Providence, Rhode Island
      Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
    Feb 2, 2022

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Head Cancer, Neck Cancer Trial in Grenoble, Lyon, Pierre-Bénite (CHEMRAD assay)

    Completed
    • Head Cancer
    • Neck Cancer
    • CHEMRAD assay
    • Grenoble, France
    • +3 more
    Dec 23, 2021

    Advanced Cancer Trial in Belgium, France (AsiDNA)

    Completed
    • Advanced Cancer
    • Bruxelles, Belgium
    • +4 more
    Mar 23, 2022

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Cancers With DNA Repair-Deficiency Trial in Germany (Olaparib, Physician's choice, Trabectedin)

    Recruiting
    • Cancers With DNA Repair-Deficiency
    • Dresden, Germany
    • +8 more
    Jan 12, 2022

    Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus

    Not yet recruiting
    • Locally Advanced Leiomyosarcoma
    • +6 more
    • Niraparib Tosylate Monohydrate
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 25, 2022

    Prostate Cancer Trial in Porto Alegre, Sao Paulo (Nivolumab)

    Active, not recruiting
    • Prostate Cancer
    • Porto Alegre, Rio Grande Do Sul, Brazil
    • +1 more
    Aug 24, 2021

    Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

    Recruiting
    • Metastatic Pancreatic Cancer
    • Barcelona, Spain
    • +2 more
    Dec 29, 2022

    Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

    Not yet recruiting
    • Advanced Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 12, 2022